Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2192 (LINC02192)

Target
LINC02192
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2192 (LINC02192) is a member of the lincRNA subclass of long non-coding RNAs, defined as autonomously transcribed RNAs longer than 200 nucleotides that do not overlap protein-coding genes. lincRNAs are implicated in diverse biological functions such as regulation of gene expression, chromatin remodeling, and transcriptional control, often acting as molecular scaffolds or by modulating the stability and translation of RNA transcripts. Although the specific function of LINC02192 is not fully established, it has been identified via integrative transcriptomic analyses as one of several lncRNAs downregulated in lung cancer, suggesting potential as a diagnostic biomarker for non-small cell lung cancer. Like other lincRNAs, it may play roles in fine-tuning gene expression, but its therapeutic targeting or drug interactions have not been reported. The clinical utility of LINC02192 as a biomarker remains to be experimentally validated

Other names
LINC02192
02

Biological functions

Regulation of gene expression (epigenetic and transcriptional regulation)Potential chromatin remodeling and scaffoldingPossible regulation of neighboring gene expression in cis or trans
03

Disease associations

Cancer (specifically noted as a potential biomarker for non-small cell lung cancer and implicated in lung cancer diagnosis and tumorigenesis)
04

Biomarkers

Potential diagnostic biomarker for lung cancer (candidate for non-invasive blood-based diagnosis according to cross-platform biomarker studies)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2192 (LINC02192).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2192 (LINC02192).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call